The proposed telehealth-prescribing rules from the Drug Enforcement Administration could require digital addiction providers to fundamentally change their business model and limit patient access to virtual addiction treatment.
These new rules will likely hit patients with the least access to status quo treatment models the hardest, especially for access to medication-assisted treatment (MAT).
“Roughly 75% of our patient population would be impacted, and therefore at risk [of being barred from care] given the changes that would be necessary to stay in compliance,” Sam Arsenault Wilson, chief quality officer and co-founder at Confidant Health, told Behavioral Health Business. Read more.
